Article
Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial.
Scientific reports - 14 Mar 2024
DeMerle Kimberley M, Kennedy Jason N, Chang Chung-Chou H, Delucchi Kevin, Huang David T, Kravitz Max S, Shapiro Nathan I, Yealy Donald M, Angus Derek C, Calfee Carolyn S, Seymour Christopher W
Abstract excerpt
Sepsis is a heterogeneous syndrome and phenotypes have been proposed using clinical data. Less is known about the contribution of protein biomarkers to clinical sepsis phenotypes and their importance for treatment effects in randomized trials of resuscitation. The objective is to use both clinical and biomarker data in the Protocol-Based Care for Early Septic Shock (ProCESS) randomized trial to determine sepsis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
